Registered number
11801370
Eclipse Pharma Limited
Filleted Accounts
30 April 2024
Eclipse Pharma Limited
Registered number: 11801370
Balance Sheet
as at 30 April 2024
Notes 2024 2023
£ £
Fixed assets
Intangible assets 3 1,610,330 1,688,330
Tangible assets 4 22,953 25,374
1,633,283 1,713,704
Current assets
Stocks 269,699 274,748
Debtors 5 739,556 77,087
Cash at bank and in hand 557,433 717,910
1,566,688 1,069,745
Creditors: amounts falling due within one year 6 (419,714) (496,111)
Net current assets 1,146,974 573,634
Total assets less current liabilities 2,780,257 2,287,338
Creditors: amounts falling due after more than one year 7 (797,360) (858,418)
Net assets 1,982,897 1,428,920
Capital and reserves
Called up share capital 1 1
Profit and loss account 1,982,896 1,428,919
Shareholder's funds 1,982,897 1,428,920
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mohammed Umar Mahmood
Director
Approved by the board on 12 June 2024
Eclipse Pharma Limited
Notes to the Accounts
for the year ended 30 April 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings over 50 years
Leasehold land and buildings over the lease term
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 5 years
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 10 10
3 Intangible fixed assets £
Goodwill:
Cost
At 1 May 2023 1,989,996
At 30 April 2024 1,989,996
Amortisation
At 1 May 2023 301,666
Provided during the year 78,000
At 30 April 2024 379,666
Net book value
At 30 April 2024 1,610,330
At 30 April 2023 1,688,330
Goodwill is being written off in equal annual instalments over its estimated economic life of 15 years.
4 Tangible fixed assets
Land and buildings Plant and machinery etc Total
£ £ £
Cost
At 1 May 2023 15,691 21,179 36,870
At 30 April 2024 15,691 21,179 36,870
Depreciation
At 1 May 2023 - 11,496 11,496
Charge for the year - 2,421 2,421
At 30 April 2024 - 13,917 13,917
Net book value
At 30 April 2024 15,691 7,262 22,953
At 30 April 2023 15,691 9,683 25,374
5 Debtors 2024 2023
£ £
Trade debtors 121,056 48,587
Other debtors 618,500 28,500
739,556 77,087
6 Creditors: amounts falling due within one year 2024 2023
£ £
Trade creditors 189,647 320,645
Taxation and social security costs 216,071 134,385
Other creditors 13,996 41,081
419,714 496,111
7 Creditors: amounts falling due after one year 2024 2023
£ £
Bank loans 588,325 640,052
Other creditors 209,035 218,366
797,360 858,418
8 Other information
Eclipse Pharma Limited is a private company limited by shares and incorporated in England. Its registered office is:
413 Hoe Street
London
E17 9AP
Eclipse Pharma Limited 11801370 false 2023-05-01 2024-04-30 2024-04-30 VT Final Accounts July 2024 Mohammed Umar Mahmood No description of principal activity 11801370 2022-05-01 2023-04-30 11801370 core:WithinOneYear 2023-04-30 11801370 core:AfterOneYear 2023-04-30 11801370 core:ShareCapital 2023-04-30 11801370 core:RetainedEarningsAccumulatedLosses 2023-04-30 11801370 2023-05-01 2024-04-30 11801370 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 11801370 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 11801370 bus:Director40 2023-05-01 2024-04-30 11801370 1 2023-05-01 2024-04-30 11801370 2 2023-05-01 2024-04-30 11801370 core:Goodwill 2023-05-01 2024-04-30 11801370 core:LandBuildings 2023-05-01 2024-04-30 11801370 core:PlantMachinery 2023-05-01 2024-04-30 11801370 countries:England 2023-05-01 2024-04-30 11801370 bus:FRS102 2023-05-01 2024-04-30 11801370 bus:FilletedAccounts 2023-05-01 2024-04-30 11801370 2024-04-30 11801370 core:WithinOneYear 2024-04-30 11801370 core:AfterOneYear 2024-04-30 11801370 core:ShareCapital 2024-04-30 11801370 core:RetainedEarningsAccumulatedLosses 2024-04-30 11801370 core:Goodwill 2024-04-30 11801370 core:LandBuildings 2024-04-30 11801370 core:PlantMachinery 2024-04-30 11801370 2023-04-30 11801370 core:Goodwill 2023-04-30 11801370 core:LandBuildings 2023-04-30 11801370 core:PlantMachinery 2023-04-30 iso4217:GBP xbrli:pure